Belgian REIT Cofinnimo continues to spend across Europe making its latest acquisitions in Germany and France and building a new nursing and care home in Andalusia.
Spain will spend over €450m on the digitalisation of its primary care sector, building a new data network and AI as part of a new €1.5bn healthcare budget. The sector, however, says it is not enough.
Biogroup, the fast consolidator of the French lab market, has moved into the Iberian peninsular for the first time by acquiring two assets: Analiza and Cerba Internacional. HBI hears the multiple looks very, very low.
Top Doctors, the third biggest doctor-booking platform in private healthcare after EU-based Doctolib and global player DocPlanner, has raised $13m to improve its digital tools and grow in key sectors. HBI chats with Alberto E. Porciani, CEO of Top Doctors to find out more.
HBI hears that the owners of German/Swiss dermatology group Corius will be assessing exit options after it closes a round of financing in the next month.
Vascular access thrombosis is an expensive and painful complication for dialysis patients, with an incident rate of 0.11-0.5 episodes per patient per year. Global dialysis provider Diaverum has started to roll out an algorithm that can predict 75% of cases missed by current practices, enabling earlier interventions.
Francesco De Meo, CEO of Fresenius Helios, told HBI 2021 that Fresenius plans to expand from treating 20m patients per year in Europe to treating 100m per year globally by 2030. To achieve this he emphasised the role of asset light models with a heavy focus on digital.
Demand for and interest in dental services from patients and investors continues to rise, with increased respect for dental platforms and a heightened awareness of aesthetic procedures.
Infertility is up, maternity in many regions is down - and the global fertility market is continuing on an upwards trajectory largely untouched by Covid. It remains a hot ticket when it comes to M&A - though issues with regulation and staffing are causing some headaches.
Spain may regret dismantling its pioneering Alzira model. HBI hears that costs have nearly tripled since it booted Ribera Salud out of the Valencian project. A similar fate might await Torrevieja, which expires next month.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.
